A hallmark of our laboratory has been the development of quantitative techniques to gain insight into the physiological processes which limit the effective us of therapeutic agents. The primary scientific focus of this core involves three such fields related by their bioengineering emphasis: mathematical modeling, intravital microscopy, and image analysis. Two other important systems are: maintenance of a variety of estimation. Mathematical modeling will be used to help understand transport barriers on a number of length scales and for a variety of therapeutic agents. Whole body organ level, microscopic, and in vitro models have been developed and used successfully in the past by the lab. In the proposed PPG this aspect of the bioengineering core will be essential in interpreting data in all four projects, e.g. deconvolution of green fluorescence protein signals to quantify gene expression, analyzing data for vascular permeability, interstitial flow and solute transport, and cell trafficking and biodistribution studies. Each project relies on microscopy to quantify microenvironment, gene expression physiological and biophysical parameters. The bioengineering core will therefore acquire and maintain microscopes, other optical equipment, and related electronic and imaging methods (e.g. fluorescent correlation spectroscopy, continuing the tradition established over the past decade. Core leaders will instruct and assist researchers in the use of microscopy techniques and image analysis software. Image analysis requires the collection, manipulation, analysis, and visualization of complex visual data obtained in all projects. Since this involves considerable and detailed knowledge of software and hardware, software and networks, programming, and interfacing is best performed with a knowledgeable computer systems manager. Finally, the quantitative aspects of our research methods require close involvement with a biostatistician in allo phases of the research: experimental design (protocols and animal calculations), analysis of experimental data, and careful estimation of model parameters with non-linear regression techniques. The four research projects in this PPG could not be carried out if the services of the bioengineering core component were not available.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
1P01CA080124-01A1
Application #
6402411
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2000-08-11
Project End
2005-07-31
Budget Start
Budget End
Support Year
1
Fiscal Year
2000
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Pereira, Ethel R; Kedrin, Dmitriy; Seano, Giorgio et al. (2018) Lymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in mice. Science 359:1403-1407
Dixon, Karen O; Schorer, Michelle; Nevin, James et al. (2018) Functional Anti-TIGIT Antibodies Regulate Development of Autoimmunity and Antitumor Immunity. J Immunol 200:3000-3007
Samaha, Heba; Pignata, Antonella; Fousek, Kristen et al. (2018) A homing system targets therapeutic T cells to brain cancer. Nature 561:331-337
Binnewies, Mikhail; Roberts, Edward W; Kersten, Kelly et al. (2018) Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med 24:541-550
Nia, Hadi T; Datta, Meenal; Seano, Giorgio et al. (2018) Quantifying solid stress and elastic energy from excised or in situ tumors. Nat Protoc 13:1091-1105
Ina Ly, K; Vakulenko-Lagun, Bella; Emblem, Kyrre E et al. (2018) Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI. Sci Rep 8:17062
Nowak-Sliwinska, Patrycja; Alitalo, Kari; Allen, Elizabeth et al. (2018) Consensus guidelines for the use and interpretation of angiogenesis assays. Angiogenesis 21:425-532
Zhao, Yingchao; Liu, Pinan; Zhang, Na et al. (2018) Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma models. Proc Natl Acad Sci U S A 115:E2077-E2084
Hong, Theodore S; Grassberger, Clemens; Yeap, Beow Y et al. (2018) Pretreatment plasma HGF as potential biomarker for susceptibility to radiation-induced liver dysfunction after radiotherapy. NPJ Precis Oncol 2:22
Pinter, Matthias; Kwanten, Wilhelmus J; Jain, Rakesh K (2018) Renin-Angiotensin System Inhibitors to Mitigate Cancer Treatment-Related Adverse Events. Clin Cancer Res 24:3803-3812

Showing the most recent 10 out of 320 publications